Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
3 studies found for:    20672358 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia;   Acute Lymphoid Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: azacitidine;   Biological: donor lymphocyte infusion
2 Active, not recruiting Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Azacitidine;   Drug: Vorinostat
3 Active, not recruiting Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia
Intervention: Drug: Decitabine
To Top

† Indicates status has not been verified in more than two years